(PEGA, TKMR,QLTI) CRWENewswire Stocks In Action
Pegasystems Inc - PEGA - reported that its GAAP net income for 2011 was $10.1 million, compared to GAAP net loss of $5.9 million for 2010. QLT Inc - QLTI - announced positive preliminary results from its Phase 1b trial of QLT091001 in subjects With Retinitis Pigmentosa Due to retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase Mutations. Tekmira Pharmaceuticals Corp - TKMR - reported that it is adding a new RNAi therapeutic targeting ALDH2 for the treatment of alcohol-dependence to its product pipeline.

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

ユーザー：karmastock
再生時間：00:01:14
投稿日時：12/03/02 4:41
カテゴリ：ビジネス全般 
タグ： PEGA  QLTI  TKMR  Nasdaq:PEGA  Nasdaq:TKMR  Nasdaq:QLTI 

[ 前ページへ戻る ]